Last updated on: 06/02/2013
1. Contact details
This data source is maintained by the following centre registered in the ENCePP inventory of research centres: IMS Health
Name of data sourceIMS LifeLink : Longitudinal Prescription Data - Japan
Name under which the data source should be displayed in the inventory (e.g short name if one exists)IMS LifeLink : Longitudinal Prescription Data - Ja
Name of organisation
1) Department/research groupReal World Evidence Solutions
2) Organisation/affiliationIMS Health
Administrative Contact
Title Dr
Last name Massoud
First name Toussi
Address line 15-7 place des Pyramides
Address line 2
Address line 3
CityParis La Défense
Postcode92088
CountryFrance
Scientific Contact
Title Dr
Last name Massoud
First name Toussi
Address line 15-7 place des Pyramides
Address line 2
Address line 3
CityParis La Défense
Postcode92088
CountryFrance
2. Description/category
Pharmacy dispensing database
3.1 Coverage of licensed medicinal products
Licensed Medicinal Product
Comments
Community / general practice data
3.2 ATC code (5th level)
No
3.3 Other product dictionaries
EphMRA
3.4 Recording of indication for use
No
4. Coverage of events
Event
Dictionary
Dictionary details
No events
5. Year of establishment
2008
6. Geographical origin of data
Non EEA/EFTA areas
Asia
7. Demographical extent of data collection
Nation-wide
8. Age groups
17 years and under [Paediatrics]
preterm newborn infants
term newborn infants (0 to 27 days)
infants and toddlers (28 days to 23 months)
children (2 to 11 years)
adolescents (12 to 17 years)
18 to 45 years
46 to 64 years
65 years and over
65 to 75 years
76 years and over
9. Size of the source/catchment population
10 a. Total (cumulative) number of persons with actual data
10 b. Number of persons with active data collection in past calendar year
9,740,000
11. Possibility to obtain additional information on the patient
a) Clinical information from treating physician?
No
b) Questionnaire data from the patient?
No
c) Genetic information or samples?
No
12. Possibility of links to other sources of data
No
13. Written policy governing data access
Yes
14. Committee to evaluate requests for data access
No
15. Charge/fee for data access
Yes
Special arrangements for academic purposes:
Yes
16. Selected publications of the last 5 calendar years using data from this data source
ReferenceLink to web-publication
Aya Furukawa, Jin Uesawa, Ouki Sasaki, Kazuhiro Mawatari, Shuichi Beppu, Toshiaki Nakamura, Toshiki Hirai. Evaluation of revision of precaution in Drug Usage. (Collaborative work of IMS Japan and Medical Department, University Of Fukui). Presented at the annual session of Japanese Society of Drug Informatics, held on 23th July, 2011.
Aya Furukawa, Jin Uesawa, Tatsuya Koga, Toshiki Mano, Toshiki Hirai. Evaluation of Effectiveness of Risk Communication for Medication Therapy. Published in magazine “Medical care and Society”, April, 2011.
